Advertisement
Organisation › Details
Innervation Pharmaceuticals (CH)
Innervation Pharmaceuticals is a pre-clinical phase biotech. Its patented, solid-phase transfection platform is used for genome-wide screening services and the discovery of genes that boost neuronal regrowth after spinal cord injury. *
Start | 2019-10-03 existent | |
Industry | cancer immunotherapy (immuno-oncology, I-O) | |
Region | Basel BS | |
Country | Switzerland | |
City | n. a. Basel Area | |
Address record changed: 2020-05-16 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: BaseLaunch (BaselArea.swiss). (10/3/19). "Press Release: 15 Companies Chosen for Phase 1". Basel. | ||
Record changed: 2023-07-10 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top